← All trials
NCT02999295
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2017
- Primary completion
- Jun 1, 2019
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 44
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- National Cancer Center, JapanLead sponsor
- National Cancer Center, JapanOverall official - principal investigator
- National Cancer Center, JapanReponsible party - principal investigator
- Clinical Study Support, Inc.Collaborator
- Fiverings Co., Ltd.Collaborator
- Ono PharmaceuticalsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.